Re: Why "X treatment crashed me bro" is counterintuitive to the reality of these conditions, and that which makes you feel a little bad may be in reality, what you need to recover. I think I have figured out the true nature of the low libido/anhedonia/substance resistance in PFS/PSSD and how to fix it.
u/drwillpowers
r/DrWillPowers2026-09-12T18:10:57Z
Dr Will Powers’ own statements and theorizing
Mentions treatments or doses — not guidance
Summary (paraphrased)
Powers explained his use of indomethacin as the only available "hammer" for lowering THDOC, while noting he lacks good alternatives — one patient with a single kidney cannot take NSAIDs, diazepam inhibits THDOC synthesis but is itself a GABA-A agonist, dexamethasone suppresses ACTH-driven adrenal DOC synthesis but is suboptimal, and medroxyprogesterone (which inhibits THDOC in rats) suppresses male libido. He acknowledged he could be wrong about the mechanism, having no CSF tap to prove it — only Melcangi's data, which he says supports his theory — plus other plausible indomethacin mechanisms (COX/prostaglandin, AKR1C3/11-oxygenated-androgen, or FAAH/endocannabinoid effects). He argued the biochemistry was unsolved because it is complicated: not one mutation but a combination of multiple rare mutations that together reduce androgen metabolism and excretion capacity, which is why GWAS studies failed — most people simply lack enough of them. He said the true pattern was that every patient had some lab value that made no sense relative to the others, a pattern he could recognize from 16 years of reading transgender-medicine labs. On the suppression trial itself, he described patients regaining androgenic signs (body odor, acne) within a week of starting — absurd under traditional thinking — and interpreted it as astronomical intracellular androgen pile-up that serum values fail to reflect, such that falling serum levels clear the metabolite backlog and pass through a genuinely functional signaling level on the way down. He closed by framing the remaining questions as whether the system fully resets or needs a maintenance modifier, and by noting that hundreds of patients sequencing their own genomes and collaborating represents something unprecedented in modern medicine.
Key points (paraphrased)
- Indomethacin is his current tool against THDOC; alternatives (diazepam, dexamethasone, medroxyprogesterone) each have disqualifying trade-offs.
- Admits the mechanism is unproven without CSF data; lists alternative indomethacin mechanisms (COX, AKR1C3, FAAH).
- PFS/PSSD vulnerability = polygenic pile-up of rare mutations reducing androgen metabolism/excretion — explains GWAS failure.
- Diagnostic pattern: individually incoherent lab values relative to each other, legible only with deep lab-ratio expertise.
- Suppression-trial paradox (androgenic signs returning during castration) interpreted as intracellular androgen pile-up invisible in serum.
- Community genome-sequencing collaboration described as unprecedented.
Why it’s in the corpus
A compact statement of three corpus-central ideas: the polygenic "many small mutations" model that explains why GWAS missed PFS, the intracellular-pile-up hypothesis that resolves the castration paradox, and his admitted evidentiary limits (no CSF data yet). Directly relevant to pharmacology/genetics relationships and to evaluating his claims' epistemic status.
Context — the post Powers was replying toVerbatim third-party text, shown for context only — not Powers’ statement. Usernames removed.ShowHide
Powers' comment replies to a community member:
Hi dr., are you basing your conclusion that it fixes androgen signaling on the results from that single first patient (mile high guy), or are you seeing this in other patients undergoing castration under your supervision as well?
(Parent context recovered from the r.genit.al mirror on 2026-10-07; Powers' comment text itself is from John's user-provided export.)
Some fields on this page come from the release’s Markdown edition, which carries text the JSON edition omits.
Related records
- Powers · Reddit commentCurated Powers pick
Re: The Problems with the Theory of Impaired Androgen Signaling caused by Metabolite Accumulation: A Peaceful Challenge to Dr. Powers’ Thesis
u/drwillpowers · r/DrWillPowers
Long reply to a community member's critique of his impaired-androgen-signaling theory. Powers concedes his earlier strong claim — that androgens must exit through DHT when UGTs are impaired — was overstated: testosterone can route through oxidation…
AKR1C3ARUGT2B17PRH-01172026-09-20T19:15:54ZPFSPowers Reddit history - Powers · Reddit commentCurated Powers pick
Re: The Problems with the Theory of Impaired Androgen Signaling caused by Metabolite Accumulation: A Peaceful Challenge to Dr. Powers’ Thesis
u/drwillpowers · r/DrWillPowers
First half of a two-part reply in the same critique thread. Powers reports clinical observations — PFS patients regrowing hair while on treatment, and multiple cases of osteopenia/osteoporosis suggesting failed androgenic or estrogenic signaling. He says…
UGT2B17PRH-01272026-09-19T16:47:22ZPFSPSSDPowers Reddit history - Powers · Reddit post
I think I have figured out at least one specific phenotype of PFS, and it is different from the "allopregnanolone" theory
u/drwillpowers · r/DrWillPowers
Powers' key genetics-first post: he proposed a specific PFS phenotype whose "base, core defect" is defective UGT2B17, disabling testosterone's main glucuronidation exit pathway. Carriers show shockingly low 3α-androstanediol glucuronide and near-zero urinary…
AKR1C1AKR1C2AKR1C3AKR1C4HSD17B2+3DWP-0032026PFSCore corpus
